Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
60-Word AI Digest
Max Hodak, the former president and co-founder of Neuralink, detailed onstage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Key Takeaways
- Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
- Max Hodak, the former president and co-founder of Neuralink, detailed onstage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
- Click full coverage link below for the complete official dispatch.
Max Hodak, the former president and co-founder of Neuralink, detailed onstage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Original Publisher Attribution
This summary was curated from TechCrunch.